Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease.
暂无分享,去创建一个
Javed Khan | Markus Ringnér | Michael L Bittner | Jeffrey M Trent | Roland Martin | Bibiana Bielekova | Paul S Meltzer | M. Bittner | M. Ringnér | P. Meltzer | J. Trent | J. Khan | Yidong Chen | Seungchan Kim | A. Elkahloun | Roland Martin | H. McFarland | R. Bomprezzi | B. Bielekova | Seungchan Kim | Yidong Chen | Abdel Elkahloun | Henry F McFarland | Roberto Bomprezzi | Aimee Yu | Aimee Yu
[1] Wiklund Ra,et al. First of two parts , 1997 .
[2] J. Oksenberg,et al. The complex genetic aetiology of multiple sclerosis. , 2000, Journal of neurovirology.
[3] J. Witte,et al. Genetic dissection of complex traits , 1996, Nature Genetics.
[4] D. Clayton,et al. Age-adjusted recurrence risks for relatives of patients with multiple sclerosis. , 1996, Brain : a journal of neurology.
[5] B. Weinshenker,et al. Multiple sclerosis. , 2000, The New England journal of medicine.
[6] L. Hood,et al. Susceptibility for multiple sclerosis is determined, in part, by inheritance of a 175-kb region of the TcR Vβ chain locus and HLA class II genes , 1993, Journal of Neuroimmunology.
[7] W. Leonard,et al. IL-2 negatively regulates IL-7 receptor alpha chain expression in activated T lymphocytes. , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[8] G. Zimmerman,et al. Platelet-activating Factor Acetylhydrolases* , 1997, The Journal of Biological Chemistry.
[9] Short cut to disease genes. , 2001 .
[10] R. Bassel-Duby,et al. ZBP-89, a Krüppel-like zinc finger protein, inhibits epidermal growth factor induction of the gastrin promoter , 1996, Molecular and cellular biology.
[11] Paul M. Allen,et al. Partial T cell signaling: Altered phospho-ζ and lack of zap70 recruitment in APL-induced T cell anergy , 1994, Cell.
[12] M. Peter,et al. Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[13] M. Hendzel,et al. Rapid exchange of histone H1.1 on chromatin in living human cells , 2000, Nature.
[14] A. Bowcock,et al. Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. , 2001, Human molecular genetics.
[15] R. Cuesta,et al. Control of mRNA decay by heat shock-ubiquitin-proteasome pathway. , 1999, Science.
[16] A. Sadovnick,et al. Genetics of Multiple Sclerosis , 1998, Seminars in neurology.
[17] W. Leonard,et al. IL-2 negatively regulates IL-7 receptor α chain expression in activated T lymphocytes , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[18] E. Lander,et al. Genetic dissection of complex traits science , 1994 .
[19] D. McFarlin,et al. Immunological aspects of demyelinating diseases. , 1992, Annual review of immunology.
[20] T. Schumacher,et al. CD27 is required for generation and long-term maintenance of T cell immunity , 2000, Nature Immunology.
[21] M. Ringnér,et al. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks , 2001, Nature Medicine.
[22] J. Todd,et al. Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models. , 2001, Immunity.
[23] Thomas M. Aune,et al. Cutting Edge: Molecular Portrait of Human Autoimmune Disease1 , 2002, The Journal of Immunology.
[24] A. Fornace,et al. Mice lacking the p53-effector gene Gadd45a develop a lupus-like syndrome. , 2002, Immunity.
[25] C. Pozzilli,et al. The immune response to Mycobacterial 70-kDa heat shock proteins frequently involves autoreactive T cells and is quantitatively disregulated in multiple sclerosis , 1996, Journal of Neuroimmunology.
[26] N. Risch,et al. Evidence for genetic basis of multiple sclerosis , 1996, The Lancet.
[27] J. Klein,et al. The HLA system. First of two parts. , 2000, The New England journal of medicine.
[28] L. Staudt,et al. Complex immunomodulatory effects of interferon‐β in multiple sclerosis include the upregulation of T helper 1‐associated marker genes , 2001, Annals of neurology.
[29] J. Puck,et al. Inherited Human Caspase 10 Mutations Underlie Defective Lymphocyte and Dendritic Cell Apoptosis in Autoimmune Lymphoproliferative Syndrome Type II , 1999, Cell.
[30] Edward R. Dougherty,et al. Small Sample Issues for Microarray-Based Classification , 2001, Comparative and functional genomics.
[31] Keiji Tanaka,et al. Conditional Knockdown of Proteasomes Results in Cell-cycle Arrest and Enhanced Expression of Molecular Chaperones Hsp70 and Hsp40 in Chicken DT40 Cells* , 2003, The Journal of Biological Chemistry.
[32] T. Behrens,et al. Delineating the genetic basis of systemic lupus erythematosus. , 2001, Immunity.
[33] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[34] J. Haines,et al. The genetic epidemiology of multiple sclerosis , 2003, Journal of Neuroimmunology.
[35] M. Ramanathan,et al. In vivo gene expression revealed by cDNA arrays: the pattern in relapsing–remitting multiple sclerosis patients compared with normal subjects , 2001, Journal of Neuroimmunology.
[36] Ash A. Alizadeh,et al. Individuality and variation in gene expression patterns in human blood , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[37] C. Martínez-A,et al. Cell-cycle regulation in immunity, tolerance and autoimmunity. , 2000, Immunology today.
[38] J. Parisi,et al. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.
[39] D. Brenner,et al. Prolonged activation of jun and collagenase genes by tumour necrosis factor-α , 1989, Nature.
[40] L. Staudt,et al. Analysis of gamma c-family cytokine target genes. Identification of dual-specificity phosphatase 5 (DUSP5) as a regulator of mitogen-activated protein kinase activity in interleukin-2 signaling. , 2003, The Journal of biological chemistry.
[41] M. Sharief,et al. Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis , 1991 .
[42] S. Sawcer,et al. The Genetic Analysis of Multiple sclerosis in EuropeanS: concepts and design , 2003, Journal of Neuroimmunology.
[43] N. Risch,et al. A genetic basis for familial aggregation in multiple sclerosis , 1995, Nature.
[44] Nicholas J. Hoogenraad,et al. Molecular Chaperones Hsp90 and Hsp70 Deliver Preproteins to the Mitochondrial Import Receptor Tom70 , 2003, Cell.
[45] S. Reed,et al. Mitotic role for the Cdc28 protein kinase of Saccharomyces cerevisiae. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[46] F. Holstege,et al. The human T cell transcription factor-1 gene. Structure, localization, and promoter characterization. , 1992, The Journal of biological chemistry.
[47] Michael L. Bittner,et al. Strong Feature Sets from Small Samples , 2002, J. Comput. Biol..
[48] A. Sadovnick,et al. Genetic epidemiology of multiple sclerosis: A survey , 1994, Annals of neurology.
[49] N. Risch,et al. Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group. , 1996, Lancet.
[50] Wing Hung Wong,et al. Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array. , 2003, Physiological genomics.
[51] N. Sampas,et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling , 2000, Nature.
[52] C Dosne Pasqualini,et al. The HLA system. , 1979, Medicina.